#Phase 3

All articles tagged with "Phase 3"

Incyte Moves Toward a Vitiligo Filing After Twin Phase 3 Successes

Incyte says its JAK1 inhibitor povorcitinib met goals in twin Phase 3 trials in nonsegmental vitiligo, setting up a regulatory filing and putting fresh attention on the autoimmune skin disorder market.

Key Takeaways

Incyte says povorcitinib succeeded in twin Phase 3 vitiligo trials.
The company plans to seek approval in nonsegmental vitiligo.

DT Editorial Team·Apr 28, 2026·via endpoints.news

Phase 3 CRISPR Success Gives Gene Editing a New Clinical Milestone

Intellia Therapeutics says a gene-editing treatment for hereditary angioedema succeeded in Phase 3, marking what the company describes as the first Phase 3 CRISPR readout and a consequential step for the field.

Key Takeaways

Intellia says its gene-editing treatment for hereditary angioedema succeeded in Phase 3.
The result is framed as the company’s first Phase 3 CRISPR readout, making it a significant field milestone.

DT Editorial Team·Apr 28, 2026·via endpoints.news

Tanabe reports a Phase 3 win in rare light-triggered pain disorders

Tanabe Pharma says it has posted positive Phase 3 data for an oral drug targeting two rare disorders associated with pain on light exposure, marking a major clinical milestone after its Bain Capital acquisition.

Key Takeaways

Endpoints reports positive Phase 3 data for Tanabe’s oral drug in two rare diseases linked to pain on light exposure.
The result is described as the company’s first major clinical milestone after its Bain Capital acquisition.

DT Editorial Team·Mar 29, 2026·via endpoints.news